Loading...
XNAS
AHCO
Market cap1.24bUSD
Jul 18, Last price  
9.22USD
1D
0.22%
1Q
18.36%
IPO
-7.80%
Name

Adapthealth Corp

Chart & Performance

D1W1MN
P/E
13.76
P/S
0.38
EPS
0.67
Div Yield, %
Shrs. gr., 5y
43.14%
Rev. gr., 5y
43.84%
Revenues
3.26b
+1.90%
174,316,366192,559,144345,278,337529,644,0001,056,389,0002,454,535,0002,970,595,0003,200,177,0003,260,975,000
Net income
90m
P
-3,793,424-6932,086,09412,237,000-58,718,000156,175,00069,316,000-678,895,00090,422,000
CFO
542m
+12.73%
29,935,20645,930,63468,426,80860,418,000195,634,000275,679,000373,867,000480,666,000541,839,000
Earnings
Aug 04, 2025

Profile

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
IPO date
Feb 21, 2018
Employees
10,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
3,260,975
1.90%
3,200,177
7.73%
2,970,595
21.02%
Cost of revenue
2,939,120
2,910,704
2,734,494
Unusual Expense (Income)
NOPBT
321,855
289,473
236,101
NOPBT Margin
9.87%
9.05%
7.95%
Operating Taxes
41,239
(49,004)
24,769
Tax Rate
12.81%
10.49%
NOPAT
280,616
338,477
211,332
Net income
90,422
-113.32%
(678,895)
-1,079.42%
69,316
-55.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
(29,275)
(13,382)
BB yield
2.99%
0.50%
Debt
Debt current
60,510
130,152
67,212
Long-term debt
254,070
2,349,556
2,402,167
Deferred revenue
(137,928)
Other long-term liabilities
2,236,937
302,093
344,004
Net debt
204,833
2,401,590
2,419,379
Cash flow
Cash from operating activities
541,839
480,666
373,867
CAPEX
(306,055)
(337,463)
(391,423)
Cash from investing activities
(310,275)
(357,278)
(411,171)
Cash from financing activities
(198,949)
(92,528)
(66,051)
FCF
325,267
307,948
73,110
Balance
Cash
109,747
77,132
46,272
Long term investments
986
3,728
Excess cash
Stockholders' equity
(552,938)
(640,015)
41,602
Invested Capital
4,533,408
4,741,818
4,688,357
ROIC
6.05%
7.18%
4.50%
ROCE
8.09%
7.06%
4.89%
EV
Common stock shares outstanding
135,531
134,418
138,988
Price
9.52
30.59%
7.29
-62.07%
19.22
-21.42%
Market cap
1,290,255
31.67%
979,907
-63.32%
2,671,349
-17.91%
EV
1,502,062
3,389,713
5,097,329
EBITDA
687,189
710,067
587,279
EV/EBITDA
2.19
4.77
8.68
Interest
126,668
130,299
109,414
Interest/NOPBT
39.36%
45.01%
46.34%